Skip to main content
OpenTrials
Completed

NCT Number: NCT01214265

A Clinical Study for Magnetic Stimulation of the Posterior Tibial Nerve in Overactive Bladder

To evaluate the safety and feasibility of non-invasive magnetic stimulation of the posterior tibial nerve using the EMKinetics LoFIT Pulse System for treating patients with documented overactive bladder.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

The Incontinence and Pelvic Support Institute

Mission Viejo, California, 92691, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women >18 years of age
  • A score of > 4 on the OAB-q short form for urgency (question 1)
  • Average urinary frequency > 10 times in one 24 hour day based on a 3-day voiding diary
  • Self-reported bladder symptoms present > 3 months
  • Self-reported failed conservative care (e.g., dietary restriction, fluid restriction, bladder training, behavioral modification, pelvic muscle training, biofeedback, etc.) or use of antimuscarinics.
  • Off all anti-muscarinics for at least 2 weeks prior to enrollment
  • Capable of giving informed consent
  • Ambulatory and able to use a toilet independently, without difficulty
  • Capable and willing to follow all study-related procedures

Exclusion criteria

  • The patient is pregnant or intends to become pregnant during the course of the study. (Patients becoming pregnant during the course of the study will immediately be terminated from the study.)
  • The patient has an active urinary tract infection.
  • Neurogenic bladder
  • Botox use in bladder or pelvic floor muscles in the past year
  • Pacemakers or implantable defibrillators
  • Primary complaint of stress urinary incontinence
  • Current vaginal infection
  • Current use of InterStim
  • Current use of Bion
  • Current use of TENS in the pelvic region, back or leg
  • Previously been treated with PTNS
  • Use of investigational drug/device therapy within the past 4 weeks
  • Participating or have participated within the past 4 weeks in any clinical investigation involving or impacting gynecologic, urinary or renal function
  • Deemed unsuitable for enrollment in study by the investigators based on subjects' history or physical examination
  • The patient has metal implant from surgery or a metallic foreign body in either leg below (distal to) the knee (or permanent metallic tattoo <30cm from left ankle).
  • The patient has chronic constipation (less than two (2) bowel movements per week)
  • The patient has history of gastric or urinary retention
  • The patient has uncontrolled diabetes
  • Subjects with nerve damage, injury or surgery that would impact either tibial nerve or pelvic floor function
  • The patient is unable or unwilling to sign informed consent
  • The patient is currently on pharmacologic treatment that could affect bladder function
  • Known Cystocele >/= to Grade 3 that has not been reduced by treatment (surgery or pessary)

Treatment and study plan

EMKinetics non-invasive Magnetic neurostimulator

Device

Patients will be treated with 12 weekly sessions of magnetic stimulation of the posterior tibial nerve at 20 hz using the EMKinetics non-invasive Magnetic neurostimulator.

Primary outcomes

  1. Global Response Assessment

    Time frame: After 12 weeks of therapy

    Improved score on the Global Response Assessment (GRA) scale after 12 weeks of therapy. A score of 2 (moderately improved) or 3 (markedly improved) constitutes a responder on the 7 point scale

Secondary outcomes

  1. Urinary Frequency

    Time frame: After 12 weeks of therapy

    Change in Urinary Frequency (Voiding Diary) from Baseline to 12 weeks

  2. Urinary Incontinence

    Time frame: After 12 weeks of therapy

    Change in Urinary Incontinence (Voiding Diary) from Baseline to 12 weeks

  3. Overactive Bladder Symptoms (OAB-q SF)

    Time frame: After 12 weeks of therapy

    Change in Overactive Bladder Symptoms (OAB-q SF) from Baseline to 12 weeks

Sponsors and collaborators

Lead sponsor

EMKinetics, Inc

Industry

Registry information

Official study title

A Pilot Clinical Study to Evaluate the Initial Feasibility of Neuromodulation Therapy in Treating Patients With Overactive Bladder Via Magnetic Stimulation of the Posterior Tibial Nerve

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Oct 5, 2010
Registry last updated
Oct 26, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.